COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-86400

March 7 2023
https://pubmed.ncbi.nlm.nih.gov/36879183/
Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection

Excerpt
The meta-analysis of three trials involving 382 patients revealed that the mean time to viral clearance was 5.74 days shorter in case of ivermectin treatment compared to the control groups [WMD = -5.74, 95% CI (-11.1, -0.39), p = 0.036].
Ivermectin has significantly reduced the time to viral clearance in mild to moderate COVID-19 diseases compared to control groups.
However, more eligible studies are needed for analysis to increase the quality of evidence of ivermectin use in COVID-19.